4 results for "Longhao Cheng"
Showing 1–4 · 0.94 seconds · RSS
-
Journal Article
Targeting UAP1 with rabeprazole: a novel repurposed therapeutic strategy for multiple myeloma
BackgroundDespite significant advancements in proteasome inhibitors and immunomodulatory drugs, multiple myeloma (MM) remains largely incurable due to persistent drug resistance and frequent relapse, highlighting an urgent need for novel therapeutic targets.MethodsWe analyzed Multiple Myeloma…
-
Journal Article
Covalent-Assembly Based Fluorescent Probes for Detection of hNQO1 and Imaging in Living Cells
Human NAD(P)H: quinone oxidoreductase (hNQO1) is an important biomarker for human malignant tumors. Detection of NQO1 accurately is of great significance to improve the early diagnosis of cancer and prognosis of cancer patients. In this study, based on the covalent assembly strategy…
-
Journal Article
Metabolomics approach reveals key plasma biomarkers in multiple myeloma for diagnosis, staging, and prognosis
Abstract Background Multiple myeloma (MM) is the most aggressive and prevalent primary malignant tumor within the blood system, and can be classified into grades RISS-I, II, and III. High-grade tumors are associated with decreased survival rates and increased recurrence rates. To better understand…
-
Journal Article
Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis
Amino acid metabolic remodeling is a hallmark of cancer, driving an increased nutritional demand for amino acids. Amino acids are pivotal for energetic regulation, biosynthetic support, and homeostatic maintenance to stimulate cancer progression. However, the role of phenylalanine in multiple…